Romilkimab (Anti-IL-13 & IL-4)
Product Specifications
CAS Number
1399584-78-1
Synonyms
SAR156597
SKU
C00884-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Romilkimab is a humanized bispecific immunoglobulin-G4 antibody that targets and neutralizes IL-4 and IL-13, effectively downmodulating the inflammatory response. Its treatment significantly reduces thymus and activation-regulated chemokine (TARC) levels in patients with idiopathic pulmonary fibrosis (IPF) and significantly decreases the modified Rodnan skin score (mRSS) in patients with diffuse cutaneous systemic sclerosis (dcSSc) . MW: 198.16 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7057943-01 0.02 mg (E-Coli)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details 
MBS7057943-02 0.02 mg (Mammalian-Cell)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details 
MBS7057943-03 0.1 mg (E-Coli)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details MBS7057943-04 0.02 mg (Baculovirus)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details MBS7057943-05 0.1 mg (Mammalian-Cell)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details MBS7057943-06 0.1 mg (Baculovirus)
Recombinant Rabbit Tumor necrosis factor ligand superfamily member 4 (TNFSF4), partial
Ask
View Details